Valuation: CONMED Corporation

Market Cap 1.36B 1.22B 1.14B 1.03B 1.94B 130B 1.95B 13.61B 5.33B 67.35B 5.12B 5.01B 216B P/E 2026 *
11.7x
P/E 2027 * 10.1x
Enterprise Value 2.11B 1.88B 1.75B 1.59B 2.99B 200B 3.02B 21B 8.22B 104B 7.91B 7.73B 334B EV / Sales 2026 *
1.54x
EV / Sales 2027 * 1.4x
Free-Float
95.39%
Yield 2026 *
-
Yield 2027 * -
1 day+0.42%
1 week+2.41%
Current month-1.47%
1 month-1.62%
3 months+7.40%
6 months+18.43%
Current year+12.19%
1 week 44.05
Extreme 44.05
46.09
1 month 43.97
Extreme 43.97
48.25
Current year 31.44
Extreme 31.44
53.66
1 year 31.44
Extreme 31.44
53.66
3 years 31.44
Extreme 31.44
117.27
5 years 31.44
Extreme 31.44
159.11
10 years 31.44
Extreme 31.44
159.11
Manager TitleAgeSince
Chief Executive Officer 60 2024-12-31
Director of Finance/CFO 53 2026-07-14
Chief Tech/Sci/R&D Officer 50 2024-12-31
Director TitleAgeSince
Director/Board Member 74 2014-07-22
Director/Board Member 60 2024-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/8/26 Exercice

Director

1,000 0.0033%
7/15/26 Other

Chief Financial Officer

0 0%
7/15/26 Free

Chief Financial Officer

92,465 0.3071%
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%+2.41%+4.95%-51.22% 1.36B
+0.78%+4.53%-21.90%+12.92% 176B
+1.17%+6.80%-2.69%+29.25% 118B
-0.02%+1.56%-22.57%+9.57% 108B
-0.31%-0.27%-46.72%-10.85% 75.34B
+1.55%+4.34%+4.14%+74.68% 62.03B
+0.47%+1.09%+19.80%+67.06% 52.8B
-0.80%+3.92%+0.38%-27.57% 51.45B
-0.69%+0.95%-17.84%+22.09% 41.28B
-0.17%+0.42% - - 31.37B
Average +0.23%+2.72%-9.16%+13.99% 71.78B
Weighted average by Cap. +0.41%+3.34%-13.91%+19.71%

Financials

2026 *2027 *
Net sales 1.37B 1.22B 1.14B 1.03B 1.94B 130B 1.96B 13.63B 5.34B 67.46B 5.13B 5.02B 216B 1.43B 1.28B 1.19B 1.08B 2.04B 136B 2.05B 14.3B 5.6B 70.78B 5.38B 5.27B 227B
Net income 117M 104M 97.17M 88.09M 166M 11.08B 167M 1.16B 456M 5.76B 438M 429M 18.49B 135M 121M 112M 102M 192M 12.81B 193M 1.35B 527M 6.66B 507M 496M 21.38B
Net Debt 741M 662M 617M 560M 1.05B 70.38B 1.06B 7.4B 2.9B 36.6B 2.78B 2.72B 117B 638M 570M 531M 482M 906M 60.55B 913M 6.36B 2.49B 31.49B 2.4B 2.34B 101B
Projected Income Statement - Annual - CONMED Corporation
Logo CONMED Corporation
CONMED Corporation is a medical technology company which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product line consists of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Employees
3,900
Date Price Change Volume
26-10-13 $45.55 +0.42% 521,741
26-10-12 $45.36 +2.12% 515,221
26-10-09 $44.42 -1.53% 400,451
26-10-08 $45.11 +1.99% 473,961
26-10-07 $44.23 -0.56% 521,294
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CONMED Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
45.55USD
Average target price
45.50USD
Spread / Average Target
-0.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CONMED Corporation
  1. Stock Market
  2. Stocks
  3. CNMD Stock